| Monica Kristine Rossi Meyer, MD | |
|
300 Pasteur Dr, Stanford, CA 94305-2200 | |
| (650) 723-4000 | |
| Not Available |
| Full Name | Monica Kristine Rossi Meyer |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology - Facial Plastic Surgery |
| Location | 300 Pasteur Dr, Stanford, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205320298 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | A184458 (California) | Secondary |
| 207YS0123X | Otolaryngology - Facial Plastic Surgery | A184458 (California) | Primary |
| Entity Name | Stanford Health Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437292927 PECOS PAC ID: 6709797491 Enrollment ID: O20031124000348 |
News Archive
Brazil, Russia, India, China and South Africa are injecting new resources, momentum and innovation into efforts to improve health in the world's poorest countries, according to a report released on the eve of the 2012 BRICS Summit. Coming as many traditional donors reduce or slow their spending, the report explores the expanding influence of the BRICS on global health and development.
The Mississippi Department of Education voted on Thursday, February 18, 2016 to adopt Smart Snack standards, ensuring all public school students have healthy options beyond what is provided in the School Meal Program.
SuperNova Diagnostics, a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets for the research, development, manufacture and commercialisation of diagnostic products and services for the measurement of Neopterin, its metabolites and derivatives utilising the SuperNova technology platform of AmpCrystal.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
A new study published this month confirms the many complications of COVID-19 including cardiovascular, kidney, and lung complications.
› Verified 2 days ago
| Entity Name | Lpch Medical Group Div Of Lucile |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417907940 PECOS PAC ID: 0840298543 Enrollment ID: O20061113000232 |
News Archive
Brazil, Russia, India, China and South Africa are injecting new resources, momentum and innovation into efforts to improve health in the world's poorest countries, according to a report released on the eve of the 2012 BRICS Summit. Coming as many traditional donors reduce or slow their spending, the report explores the expanding influence of the BRICS on global health and development.
The Mississippi Department of Education voted on Thursday, February 18, 2016 to adopt Smart Snack standards, ensuring all public school students have healthy options beyond what is provided in the School Meal Program.
SuperNova Diagnostics, a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets for the research, development, manufacture and commercialisation of diagnostic products and services for the measurement of Neopterin, its metabolites and derivatives utilising the SuperNova technology platform of AmpCrystal.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
A new study published this month confirms the many complications of COVID-19 including cardiovascular, kidney, and lung complications.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Monica Kristine Rossi Meyer, MD 300 Pasteur Dr, Stanford, CA 94305-2200 Ph: (650) 723-4000 | Monica Kristine Rossi Meyer, MD 300 Pasteur Dr, Stanford, CA 94305-2200 Ph: (650) 723-4000 |
News Archive
Brazil, Russia, India, China and South Africa are injecting new resources, momentum and innovation into efforts to improve health in the world's poorest countries, according to a report released on the eve of the 2012 BRICS Summit. Coming as many traditional donors reduce or slow their spending, the report explores the expanding influence of the BRICS on global health and development.
The Mississippi Department of Education voted on Thursday, February 18, 2016 to adopt Smart Snack standards, ensuring all public school students have healthy options beyond what is provided in the School Meal Program.
SuperNova Diagnostics, a privately-held global diagnostics company for human and non-human health applications, announced today that it has signed an agreement with Shenzhen Kang Sheng Bao Bio-Technology, a biotechnology diagnostics company specializing in research, manufacture and distribution of in-vitro diagnostic kits and research reagents in China and affiliated markets for the research, development, manufacture and commercialisation of diagnostic products and services for the measurement of Neopterin, its metabolites and derivatives utilising the SuperNova technology platform of AmpCrystal.
Merck, known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) for MK-3475, Merck's investigational anti-PD-1 antibody, for the treatment of unresectable or metastatic melanoma in patients who have been previously treated with ipilimumab.
A new study published this month confirms the many complications of COVID-19 including cardiovascular, kidney, and lung complications.
› Verified 2 days ago
Zipei Feng, MD, PHD Otolaryngology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Ahmed Adher D Alsayed, MD, FRCSC Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Nikolas Hans Blevins, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Vinay Thomas Fernandes, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 875 Blake Wilbur Drive, Cc-2226a, Stanford, CA 94305 Phone: 650-736-1680 | |
Davud Baradaran Sirjani, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Dr. Yona Vaisbuch, M.D Otolaryngology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-4000 | |
Dr. Akshay Sanan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 300 Pasteur Dr, Stanford, CA 94305 Phone: 650-723-2325 |